Product category: Other bandages, dressings and accessories
REOXCARE® is used in the treatment of chronic or acute skin ulcers and diabetic foot ulcers in which the rest of products have failed. REOXCARE® is the first dressing that addresses the key factor of antioxidation as an accelerator of natural healing of chronic wounds. The differential benefits of the product have been proved in numerous postmarketing studies, showing health and economic advantages, saving over the 50% of medical cost comparing to conventional treatments. REOXCARE® is been commercialised in several European and South American countries and has already been approved for registration in various Asiatic countries. The company sought to expand its market scope looking for new commercial partners who are seek to progress at the wound care domain.
Histocell is a leading private biopharmaceutical company dedicated to the discovery, development and commercialization of new medical devices, active ingredients and cell therapies in the field of Regenerative Medicine. Since September 2018 Histocell is also dedicated to the manufacturing of its own products at newly built 2,065 m2 / 21,500 feet2 fully equipped production facilities in the heart of Bilbaos technology valley.
Its products are distinguished by their common therapeutic approach focused on the protection and regeneration of tissues damaged by oxidative and inflammatory environments and are backed up by a strong intellectual protection with 46 patents so far. Histocell is now looking for commercial partners for the distribution of its main medical device, REOXCARE®, a natural-based dressing for hard-to-heal wounds launched at the beginning of 2017.